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ABSTRACT 
 
Multiple Roles for the Zebrafish Transcriptional Activator Protein SBF/Staf.  
(May 2008) 
Kari Michele Halbig, B.S., University of Illinois-Urbana 
Chair of Advisory Committee: Dr. Gary R. Kunkel 
 
    Eukaryotic transcriptional activators stimulate transcription of genes otherwise 
expressed at low levels.  The typical activator operates by binding to specific sites on 
DNA with its activating region contacting the multiprotein machinery that directs 
transcription.  SBF/Staf is a transcriptional activator that binds to the SPH element found 
in the promoters of genes for snRNAs and genes that code for mRNAs.   SBF/Staf binds 
to SPH through a reiterated zinc finger DNA binding domain and also contains two 
distinct activation domains, one for snRNA genes and one for mRNA genes.  To test the 
role of SBF/Staf in vivo, morpholino antisense oligos were used to knock down SBF/Staf 
expression in zebrafish.  A high percentage of developing zebrafish embryos exhibited 
abnormalities.  Co-injection of a synthetic mRNA construct rescued the morpholino-
induced knockdown.  Furthermore, both the mRNA and snRNA activation domains have 
significant roles in the function of SBF/Staf because when each domain was removed 
separately, partial rescue of the knockdown phenotype was obtained. When both 
domains were removed, no rescue of the phenotype was observed.  Unexpectedly, 
knockdown of SBF/Staf expression in zebrafish embryos caused an increase in steady-
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state levels of all endogenous mRNAs tested, as well as transcripts produced from co-
injected U6 maxigenes.  However, quantitative RT-PCR analysis showed a relatively 
smaller increase in the steady-state levels of several mRNAs from genes that contain a 
SPH element in their promoters.  In zebrafish U6 genes, the SPH element is in the 
unique location of being next to the TATA box, instead of ~220 bp upstream of the start 
site as in mammals. To determine the significance of the proximally-located SPH 
element for transcription of the zebrafish U6 snRNA gene, the SPH element was 
mutated.  Transcription of a zebrafish U6 maxigene was reduced to 20.6% in transfected 
ZF4 cells and 26.8% in injected embryos, compared to that of the U6 maxigene with a 
normal promoter. This work indicates a more global role of SBF/Staf in mRNA gene 
transcription, instead of only activating the transcription of snRNA and a few mRNA 
genes, leading to an increased importance of the role of SBF/Staf in transcriptional 
control.   
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CHAPTER I 
INTRODUCTION 
 
SCOPE 
The research in this dissertation was performed to determine the biological effect 
of SBF (SPH-binding factor)/Staf (selenocysteine tRNA gene transcription activating 
factor) in zebrafish development and the significance of the proximally-located SPH 
element for transcription of zebrafish U6 snRNA genes.  This introduction provides the 
background information on the different classes of promoters transcribed by eukaryotic 
RNA polymerases and activator proteins of transcription.  The first part of the 
introduction focuses on eukaryotic RNA polymerases gene promoters, the activation 
domain of transcription activation proteins, the enhancer elements that these activators 
bind to, and the U6 snRNA gene which is the focus of our laboratory. The second part 
focuses on the endpoints of the developmental zebrafish pathways involved in 
transcriptional control. 
 
SIGNIFICANCE 
 There are many small, stable RNAs that serve essential functions in eukaryotic 
cells, which are not translated but operate in RNA-protein complexes.  Some examples  
 
This dissertation follows the style of Molecular and Cellular Biology. 
2 
 
of non-translated RNAs are ribosomal RNAs, snoRNAs for pre-ribosomal RNA 
processing, the RNA template of telomerase, and the pre-mRNA splicing cofactors U1, 
U2, U4, U5, and U6 snRNAs.  In our lab we are studying the snRNA promoters, 
specifically the human U6-1 gene promoter as a representative of a highly efficient 
promoter that provides a simple model system to study different mechanisms of 
eukaryotic transcription (38).   In vertebrates, spliceosomal snRNA genes are transcribed 
very efficiently, producing one transcript every 2-4 seconds in cultured human cells (21).  
The human U6 snRNA gene promoter contains two regions, the proximal region and the 
distal region. The proximal region, or basal promoter, contains a proximal sequence 
element (PSE) that binds the SNAP complex and a TATA box that binds a TBP (TATA 
–binding protein)-containing complex.  Together these two complexes, along with other, 
less-characterized proteins, recruit RNA polymerase III to the human U6 snRNA gene 
promoter.   A distal region contains the Oct element and the SPH element, and is located 
approximately 200-250 bp upstream from the transcriptional start site. These two 
elements are bound by the Oct-1 protein and the SPH binding factor (SBF/Staf), 
respectively.  It is this distal, enhancer-like region that allows for the U6 snRNA gene to 
have a transcription level 8-100 fold higher than basal levels.  Our laboratory has 
focused on the role of SBF/Staf in transcriptional activation.  Unexpectedly, SBF/Staf 
also stimulates transcription for a large number of protein-coding genes through a 
different activation domain (91).  In order to further study the different roles of the two 
activation domains of SBF/Staf in a whole animal, my work employed the model 
vertebrate, Danio rerio (zebrafish).  Zebrafish is a good model system to approach this 
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question because of the following: 1) SBF/Staf is conserved in vertebrates, including 
humans, mouse, zebrafish, Fugu, and Xenopus, but is absent in nonvertebrates (62); 2) 
protocols are well established for the micro-injection of anti-sense morpholino 
oligonucleotides; 3) synthetic mRNA allows for the study of gene knockdown, rescue, or 
gain of function phenotypes; and 4) zebrafish embryos are optically clear allowing for 
the phenotypic outcome of the microinjection to be visualized easily.  In the beginning 
of our investigation it was discovered that the zebrafish U6 snRNA gene promoters have 
an unusual layout in comparison to the human U6 snRNA promoter.  In zebrafish U6 
genes, the SPH element is in the unique location of being next to the TATA box, instead 
of ~220 bp upstream of the start site as in the human U6 snRNA genes and in the other 
zebrafish snRNAs.  This unusual location may facilitate the investigation of the 
mechanism of SBF/Staf activation at U6 snRNA promoters. 
 
EUKARYOTIC RNA POLYMERASES TRANSCRIBE DIFFERENT CLASSES 
OF PROMOTERS 
 Eukaryotic transcription has an increased complexity over prokaryotic 
transcription in that eukaryotic transcription uses three different RNA polymerases, 
whereas prokaryotes use only one (79).  Also, instead of binding directly to the promoter 
sequence, eukaryotic polymerases need to interact with a variety of additional proteins to 
specifically initiate transcription.  Eukaryotic RNA polymerase I is responsible for the 
transcription of the genes that encode for the 45S ribosomal RNA precursor that is then 
processed to yield the 28S, 18S and 5.8S rRNA.  RNA polymerase II transcribes the 
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genes that encode for mRNAs and U1, U2, U4, and U5 snRNAs.  The genes that encode 
for tRNAs, 5S rRNA and the U6 snRNA are transcribed by RNA polymerase III (79).   
 All genes contain a promoter that has a core sequence element that is recognized 
by a factor that binds to DNA specifically and provides a site for the formation of a 
DNA-protein complex.  The DNA-protein complex is sufficient to allow for the RNA 
polymerase to load onto the DNA.  With all three polymerases a second protein 
component is needed to connect the nucleating factor to the polymerase to form the 
preinitiation complex (110). 
 The genes transcribed by RNA polymerase I contain a promoter located 150 bp 
upstream from the transcriptional start site.  The promoter is recognized by two 
transcription factors, the upstream binding factor (UBF) and the selectivity factor 1 
(SL1).  SL1 is made up of four protein subunits and one of the units is the TATA-
binding protein (TBP).  These two factors together recruit RNA polymerase I.  Since the 
rRNA promoter does not contain a TATA-box, TBP is associated with rRNA genes by 
binding through other proteins in the SL1 complex (93). This is similar to the way that 
TBP binds with the Initiator (Inr) sequences of RNA polymerase II genes that lack a 
TATA-box. 
 Some RNA polymerase II transcribed genes contain a basal promoter with a 
TATA-box located 25-30 bp upstream from the transcription start site (108).  The basal 
transcription factor that binds to the TATA-box is TFIID, which contains TBP, and TBP 
associated factors (TAFs).  TFIIB binds to TBP and acts as a bridge to the RNA 
polymerase II-TFIIF complex.  TFIIH and TFIIE need to bind to initiate transcription.  
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TFIIH is a multi-subunit factor that is made up of two helicases and a protein kinase that 
phosphorylates the repeated sequence in the C-terminus of the RNA polymerase which 
releases the RNA polymerase from the initiation complex (79).  RNA polymerase II 
gene promoters may also have an Inr sequence that spans the start site.  Even promoters 
lacking a TATA-box still need TFIID to start transcription but the TAFs bind the Inr 
sequence instead of TBP. 
 The genes transcribed by RNA polymerase III can be divided into three groups 
based on the promoter structures and transcription factor requirements.  The first group 
is responsible for the transcription of tRNAs and contains two promoter elements, an A 
box and B box, that lie within the transcribed gene sequence.  Transcription factor 
TFIIIC binds directly to the B box and the A box orients TFIIIC to the transcriptional 
start site.  Transcription factor TFIIIB binds and recruits the RNA polymerase.  The 
second group of promoters is represented by the 5S rRNA gene (79).  The promoter 
elements for the second group are also located within the transcribed sequence and 
contain an A box and a C box.  Transcription factor TFIIIA initiates transcription by 
binding to the C box and allows for the assembly of TFIIIC, TFIIIB, and lastly, RNA 
polymerase III (110).   
 The final group does not rely on internal promoter elements and instead has 
proximal and distal promoter elements located upstream of the transcribed gene.  The 
proximal promoter is made up of a TATA-box and a proximal sequence element (PSE).  
The distal promoter contains an OCT element, that binds the Oct-1 protein and, in many 
cases, an SPH element bound by the SBF protein.  The distal region has been shown to 
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be an enhancer element (79).  One member of this group is the set of vertebrate U6 
snRNA genes whose gene product is needed to remove introns from pre-mRNA.  
 
U6 snRNA AND GENES 
U6 snRNA is a non-translated RNA that has a main role in mRNA splicing.  
During splicing the 5’ splice and branch sites are recognized partially by a base-pairing 
interaction with U1 and U2 snRNAs respectively.  Then U6 snRNA replaces U1 at the 
5’ splice site and forms a base-pairing reaction with U2 snRNA that juxtaposes the 5’ 
splice site and branch site, the reactants of the first of the two transesterification 
reactions of splicing.  Finally the two exons are bound and kept in alignment partially by 
interactions in a conserved loop in the U5 snRNA (15, 66, 100).  U6 snRNA 
mutagenesis data have defined two catalytically crucial domains that are evolutionary 
conserved:  the ACAGAGA box and the AGC triad.  Mutagenesis of either of these two 
domains leads to a block in the first and second steps of splicing (100).   
The U6 snRNA gene is a good model for the study of the regulation of 
eukaryotic transcription not only because is it highly conserved, but also because it has a 
high level of transcription.  In the human genome there are several copies of the U6 
snRNA genes dispersed throughout the genome, unlike the U1 and U2 snRNA genes 
that are tightly clustered.  In our lab, chromatin immunoprecipitation and transfection 
experiments were used to determine if the U6 snRNA genes identified via the human 
genome project were transcriptionally active.  Domitrovich and Kunkel (2003) 
determined that five of the nine U6 snRNA genes identified were transcriptionally 
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active.  The human U6 snRNA gene promoter contains two regions, the proximal region 
and the distal region. The proximal region, or basal promoter, contains a proximal 
sequence element (PSE) that binds the SNAP complex and a TATA box that binds the 
TFIIIB complex and specifies the selection of RNA pol III.  Together these two 
complexes recruit RNA polymerase III to the human U6 snRNA gene promoter.   A 
distal region contains the Oct element and the SPH element and is located approximately 
200-250 bp upstream from the transcriptional start site. These two elements are bound 
by the Oct-1 protein and the SPH binding factor (SBF/Staf), respectively (Figure 1).  
 
 
Figure 1.  Model for Transcription Complex on Human U6 snRNA Promoter. 
 
 It is this distal, enhancer-like region that allows for the U6 snRNA gene to have a 
transcriptional activity 8-100 fold higher than basal levels.   In the beginning of the 
investigation into zebrafish as a model system we discovered that zebrafish U6 snRNA 
gene promoters have an unusual organization in comparison to the human U6 snRNA 
promoter.  Zebrafish U6 genes contrast the human U6 genes in that the SPH element is 
next to the TATA box, instead of ~220 bp upstream of the start site.  This unique 
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location might facilitate the investigation into the mechanism of SBF/Staf activation at 
U6 snRNA promoters because one could study the protein-protein interactions between 
SBF/Staf and TBP.  Due to the fact that the SPH element and TATA box are located 
next to one another in the promoter of the zebrafish U6 snRNA gene the likelihood of 
SBF/Staf and TBP being physically next to each other is very likely.  This would 
increase the chance of detecting protein-protein interactions between the two proteins. 
 
TRANSCRIPTIONAL REGULATION IN EUKARYOTES 
 Eukaryotic gene transcription is an intricate biochemical process that is tightly 
regulated at many levels.  Biochemical and genetic analysis of various model organisms 
has identified a great number of protein factors responsible for transcriptional control.  
While the large assortment of gene-specific DNA-binding regulators was anticipated, the 
complexity of the general machinery in relation to prokaryotes was not.   Corresponding 
with this increased complexity in cis-control elements, 5-10% of the total coding 
capacity of metazoans is dedicated to proteins that regulate transcription (52).  These 
proteins fall into three major classes: sequence-specific DNA binding proteins that 
control gene-selective transcriptional activation or repression; general, but diverse, 
components of large multi-protein RNA polymerase machines required for promoter 
recognition; and RNA synthesis, and chromatin remodeling and modification complexes.   
 The S. cerevisiae genome encodes a total of ~ 300 transcription factors, which 
includes both sequence-specific DNA-binding proteins and subunits of general 
transcription complexes (105).  In contrast, the genome sequences of C. elegans and 
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Drosophilia reveal at least 1,000 transcription factors each and there may be as many as 
3,000 transcription factors in the human genome (3, 81).  Thus, the complexity of an 
organism correlates with an increase in both the ratio and absolute number of 
transcription factors per genome.  Yeast contains an average of one transcription factor 
per 20 genes, while humans appear to contain one factor for every ten genes (52).  Given 
that transcription factors can work in combination, this two-fold increase in the number 
of factors could produce an expansion in the regulatory complexity. 
 Metazoan genes contain highly structured regulatory DNAs that direct complex 
patterns of expression in many different cell types during development (52).  The basal 
promoter is compact and composed of ~60 bp straddling the transcription start site (See 
Figure 2). 
 
Figure 2. Complex Metazoan Transcriptional Control Modules.  A complex arrangement of 
multiple clustered enhancer modules interspersed with silencer and insulator elements which can be 
located 10-50 kb either upstream or downstream of a composite core promoter containing TATA box 
(TATA), Initiator sequence (INR), and downstream promoter element (DPE) (Modified from 53). 
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There are at least three different sequence elements that can recruit the TBP containing 
TFIID initiation complex:  TATA-box, Inr, and the downstream promoter element 
(DPE) (94).  Many genes contain binding sites for proximal regulatory factors just 
upstream of the basal promoter.  These factors do not always function as classical 
activators or repressors; instead they may serve as “tethering elements” that recruit distal 
enhancers to the basal promoter (18, 95).  Insulator DNAs prevent enhancers associated 
with one gene from inappropriately regulating a neighboring gene (16).  These 
regulatory DNAs are scattered over distances of roughly 10 kb in fruit flies and 100 kb 
in mammals.  It is this elaborate organization of the regulatory DNA elements that 
allows for the tight control of gene expression and provides an explanation for the use of 
multiple enhancers, silencers, and promoters to control the expression of an individual 
metazoan gene. 
 There are three major methods for regulating the binding and function of the 
RNA pol II complex at the basal promoter.  The first is divergent TFIID complexes that 
bind specific sequence elements within the basal promoter and recruit RNA pol II.  It is 
now clear that metazoans have evolved multiple related TFIID complexes that can 
function at distinct promoters through the use of tissue-specific TAFs and TBP related 
factors (TRFs) that are not found in yeast (Figure 3A).  One example of a tissue-specific 
TAF is TAFII105,  related to the ubiquitously expressed human TAFII130, which 
operates as part of a unique TFIID complex in follicle cells of the ovary to permit the 
selective activation of a small subset of genes (32).  The diverse TFIID complexes have 
also evolved through the duplication of TBP.  There is only one TBP gene and no TRFs 
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in yeast but there are four TRFs (TRF1-4) in addition to TBP in Drosophila (39, 43, 75, 
101).  These findings suggest that metazoans have evolved TFIID-related transcription 
complexes responsible for recognizing distinct basal promoters with specific regulatory 
activities.  
 
Figure 3.  The Multi-Subunit General Transcription Apparatus. The eukaryotic transcriptional 
apparatus can be subdivided into three broad classes of multi-subunit assembles that include the RNA 
pol II core complex and associated general transcription factors (TFIIA, TFIIB, TFIID, TFIIE, TFIIF, 
and TFIIH), multi-subunit cofactors (mediator, CRSP, TRAP, ARC/DRIP, etc) and various chromatin 
modifying or remodeling complexes (SWI/SNF, PBAF, ACF, NURF, and RSF). (Modified from 27) 
 
A second mechanism to facilitate the binding and function of RNA pol II is the 
multi-subunit transcription complexes that are related to the yeast mediator complex. 
While yeast has one mediator complex, metazoans have several related complexes: 
TRAP, CRSP, ARC/DRIP, SMCC, and hMed.  These complexes are recruited to the 
DNA through interactions with a variety of sequence-specific transcriptional activators, 
including nuclear receptors such as the vitamin D receptor and the thyroid hormone 
receptor (2, 31, 37, 76).  Like TFIID, these cofactor complexes may serve as bridges 
between activators in the distal region on the basal promoter.  However, they may not 
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function solely through the simple recruitment of RNA pol II, but can also be induced to 
undergo conformational changes that may be essential for activating transcription (96).  
The cofactor complexes represent some of the most dramatic examples of the 
diversification of general transcription complexes in evolution (41, 64, 82, 96).  Unlike 
the other components of the general transcription machinery, most of the protein 
subunits that comprise the yeast mediator and metazoan cofactor complexes are not 
highly conserved.  Thus, in contrast to the strong conservation of TFIID and RNA pol II 
subunits, cofactor complexes have diversified greatly between eukaryotes, and have 
expanded among metazoans (34, 57).  
Finally, there are enzymatic complexes that remodel or modify chromatin.  The 
enzymes that either remodel nucleosomes (Swi/Snf, Baf/Brm, Acf, and Nurf) or 
covalently modify histones via acetylation or methylation represent another potential 
source of regulatory diversification during metazoan evolution (29, 35, 45, 98, 103).  
Although such complexes are found in yeast, there is only limited conservation of 
similar subunits in mammals.  There is also emerging evidence that remodeling 
complexes such as the BAFs (Brahma-related gene (BRG1)/Brahma (BRM)-associated 
factor) have diversified in mammals along with the acquisition of specialized cell types.  
One example is the neuron-specific BAF complex in mammals, which has no apparent 
counterpart in fruit flies or nematodes (70).  Also, some of the remodeling complexes 
mediate transcriptional repression rather than activation, such as the MBD2 protein that 
controls repression on methylated DNA templates by recruiting NuRD, a complex that 
contains both a Swi/Snf activity and histone deacetylase activity (29). 
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ENHANCER ELEMENTS OF TRANSCRIPTION 
 Since their identification in the early 1980s, transcriptional enhancers have been 
the subject of numerous studies because of their ubiquitous roles in higher eukaryotic 
gene regulation.  Enhancers are classically defined as cis-acting independent of their 
position and orientation with respect to the transcriptional initiation site (7).  This 
stimulatory role distinguishes enhancers from basal promoter elements which bind the 
basal transcription machinery and determine the site of transcriptional initiation (94).  
Enhancer-associated proteins can bind in sequence-specific or sequence-non-specific 
manners, as well as indirectly through protein-protein interactions.  Typical enhancers 
span 200-1,000 bp, and bind to dozens of sequence-specific proteins (4).  Enhancer 
elements are commonly found in clusters.  Single factor binding sites are in general 
insufficient to drive gene expression, a mechanistic feature that appears to prevent 
unwanted activation by randomly occurring binding sites.  Instead, multiple, clustered 
sites are a hallmark of enhancers, and presumably reflect the synergy required for 
important, but weak, protein-protein interactions to occur (28).   
There are two manners in which enhancers are suggested to affect gene 
expression: either in a binary, “stochastic” manner, or a continuous, “rheostatic” manner.  
In the first case the transcriptional expression level of a gene has either an “on” or “off” 
state and the activity of the enhancer is to turn the gene to the “on” state (13).  The 
second, rheostatic model, suggests that enhancers might also quantitatively regulate 
transcription rates through a continuous spectrum, depending on the amount and nature 
of the bound factors. This model is supported by direct manipulation of transcription 
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factor concentrations on synthetic enhancers (10, 80) and by sequence changes that 
affect individual factor binding sites within an enhancer that also quantitatively affect 
the strength of the activation (46).   
 
ACTIVATION DOMAINS OF TRANSCRIPTION ACTIVATION PROTEINS 
Eukaryotic transcriptional activators stimulate transcription of genes otherwise 
expressed at low levels.  The typical activator operates by binding to specific sites on 
DNA, contacting  its activating region to the multiprotein machinery that directs 
transcription (73). The activation domain of a transcription activator is the region of the 
protein that recruits the basal transcriptional machinery or mediator proteins through 
protein-protein interactions to the gene promoter.  Transcriptional activators can also 
recruit chromatin remodeling factors to a specific gene promoter allowing the 
transcriptional machinery access to the promoter.  This allows for an increased level of 
transcription of a specific gene.  Activation domains do not have a well defined 
organization and have no obvious sequence similarity but may structurally have an alpha 
helix and are sometimes rich in proline, glutamine, acidic amino acids, or hydroxylated 
amino acids.  
For many activators and genes, the specificity of activation is determined solely 
by the DNA binding address of the activator (73).  For example, the activator Gal4 
ordinarily activates genes required for galactose metabolism in yeast, but when any of a 
wide array of genes is modified to contain a Gal4 binding site nearby, Gal4 will also 
activate that gene.  Gal4 contains two functional domains.  One is the DNA binding 
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domain (DBD) that binds to Gal4 UAS (upstream activation sequence) but does not 
activate transcription.  The Activation domain (AD), which is inactive on its own, works 
when fused to a heterologous DNA-binding domain to activate a reporter gene (72).  
Thus, Gal4 is a modular protein with the DBD and AD functions carried on separable 
domains.  When Gal4 was artificially expressed in a wide array of eukaryotes, it was 
found in each case to activate a reporter gene bearing Gal4 binding sites (UAS) nearby.  
Thus, the mechanism of activation is widely conserved (74).   
The recruitment model postulates that transcriptional activators, through the use 
of protein-protein interactions, recruit the transcriptional machinery to the DNA.  
Activating regions that are not tethered to DNA do not activate; they must be brought to 
the DNA for recruitment to move forward.  The activator can either lie adjacent to the 
gene or further upstream, where the DNA loops out to allow the protein-protein 
interactions.  Activation of transcription by recruitment is more complicated in 
eukaryotes than in bacteria in that an activator must recruit to the gene a more elaborate 
transcriptional machinery (57, 59).  Whereas recruitment of RNA polymerase itself 
suffices in bacteria, at least 50 proteins must be assembled in eukaryotes.  Some of these 
proteins are found in complexes and some must be independently recruited to the gene 
(14, 19).  Some of the recruited complexes modify histones to increase the affinity for 
other complexes and make the further recruiting task of an activator easier.  Recruited 
complexes interact with and attract polymerase and promote elongation of transcription.  
Therefore, the activator, by simple binding or recruiting reactions, triggers a cascade of 
events that results in expression of a specific gene (1, 42, 50).  
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THE SBF/STAF PROTEIN 
SBF/Staf is an activator protein that binds to the SPH element and 
activates/enhances the transcription of the downstream gene.  SBF/Staf was first 
demonstrated to be able to activate RNA polymerase III transcription in vivo by the 
Carbon lab (92).  SBF/Staf binds to the SPH element through a seven zinc finger DNA 
binding domain and contains two distinct activation domains, one for snRNA genes and 
one for mRNA genes that can stimulate snRNA promoters and synthetic mRNA 
promoters as determined by Schuster et al.1998 (91) (Figure 4).   
 
 
Figure 4.  Primary Structure of the Human SBF/Staf Protein. 
 
The central part of SBF/Staf contains seven contiguous zinc fingers of the C2-H2 type 
(92).  Not all of the seven zinc fingers are required for binding to SPH sites.  Zinc finger 
1 exhibits a flexible requirement, since it contacts the DNA of X.laevis tRNA
Sec
 , but not 
at the human U6-1 snRNA SPH element (86).  This flexibility allows for the maximum 
transcription activation from the xtRNA
Sec
 and human U6-1 snRNA promoters (87).  
The non-utilization of the first zinc finger at the human U6-1 snRNA promoter enables 
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the simultaneous binding of SBF/Staf and Oct-1 to their cognate DNA motifs (87).  The 
two physically separate and functionally distinct activation domains are located in the N-
terminus.  The activation domain covering residues 207 to 224 of Xenopus SBF/Staf 
functions solely in the transactivation of RNA polymerase II and RNA polymerase III 
snRNA-type promoters.  The other activation domain, residues 84-176 of the Xenopus 
protein, is restricted to transcriptional activation from mRNA promoters (91).    
Until recently, only eight protein-coding genes had been described to be 
regulated by SBF/Staf:  1)  mouse cytosolic chaperonin containing t-complex 
polypeptide 1 (TCP1) (47); 2)   human interferon regulatory factor (IRF3) (55); 3) 
human neuronal nitric oxide synthase (NOS1) (85); 4)  human transaldolase (TALDO1) 
(36); 5)  mouse aldehyde reductase (AKR1A1) (8); 6)  human mitochondrial ribosomal 
protein S11 (MRPS11) (40); 7)  human synaptobrevin-like 1 (SYBL1) (24); 8)  human 
budding uninhibited benzimidazole receptor 1 (BubR1) (61).  Vertebrates also contain 
two proteins, ZNF143 and ZNF76, which are related to SBF/Staf.  ZNF143 constitutes a 
human ortholog of SBF/Staf and ZNF76 a paralog of ZNF143 (63).  ZNF76 and 
ZNF143 are thought to play the same role.  However, recent results suggest that ZNF76 
functions as a transcriptional repressor through interactions with TBP and that 
sumoylation modulates its transcriptional properties (111).  A recent study by Myslinski, 
et. al. 2006 (60) identified 1175 SBF/Staf binding sites (SPH elements) in 938 promoters 
of four different mammalian genomes.  Thus, SBF/Staf may be one of the most 
prevalent activators for mammalian genes.  The group also demonstrated that the 
presence of the SPH elements alone were sufficient to direct the expression of a 
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luciferase reporter gene, suggesting that SBF/Staf can recruit the RNA pol II 
transcription machinery.   
 
ENDPOINTS OF PATHWAYS IN ZEBRAFISH DEVELOPMENT INVOLVE 
TRANSCRIPTIONAL CONTROL 
 In early development higher eukaryotic cells are totipotent.  The control of cell 
differentiation is controlled by selective gene expression.  Differential gene expression 
during metazoan embryogenesis typically is regulated  in response to several signaling 
transduction pathways including the Wnt, FGF (Fibroblast Growth Factor), TGF-β 
(Transforming Growth Factor Beta) super family, and Hedgehog pathways.  Loss of 
function of any member of any of these pathways will lead to disruption of embryo 
development.  The major signal transduction pathways follow similar schematic 
outlines.    Each receptor spans the cell membrane and has an extra cellular region, a 
transmembrane region, and a cytoplasmic region.  When a ligand binds to its receptor it 
causes a conformational change in the receptor’s cytoplasmic domain.  The 
conformational change gives the cytoplasmic domain an enzymatic activity, which is 
usually a kinase activity. The activated cytoplasmic domain phosphorylates a 
downstream target protein which becomes activated in response.  Eventually, the signal  
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cascade of phosphorylation will activate a dormant transcription factor.  The main 
function of these pathways is to use intercellular signaling to regulate cell fate decisions 
by altering the transcriptional program of the target cells in an instructive manner.  For 
the purpose of this study, knowledge of these pathways may help in the interpretation of 
the phenotypes seen after morpholino injection to knock down SBF/Staf levels.  An 
overall description of these signaling pathways and mutant phenotypes found after mis-
expression of members of the pathways in zebrafish follows.  
One important signalling pathway is the Wnt pathway  (33).  Wnt binds to the 
Frizzled protein receptor activating the Disheveled protein.  Activated Disheveled then 
inhibits the activity of glycogen synthase kinase-3 (GSK3).  With GSK3 inhibited, β-
catenin dissociates from the APC protein and enters the nucleus.  Once in the nucleus β-
catenin forms a heterodimer with either LEF or TCF DNA-binding proteins to become a 
transcription factor (Figure 5) (9, 17).   
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Figure 5.  The Wnt Signal Transduction Pathway. The Wnt protein binds to its receptor Frizzled 
activating Disheveled allowing it to become an inhibitor of GSK3.  β-catenin is then free to associate 
with LEF or TCF and become an active transcription factor.  (Modified from 33) 
 
Two genes in the human Wnt signaling pathway contain SPH sites in their promoters, 
Frizzled-4 and GSK3-α (60).  These sites were confirmed by visual inspection to be in 
analogous positions in the corresponding zebrafish genes.  Hence, there is a chance that 
SBF/Staf may be involved in the Wnt signaling pathway.  Three transcription factor 
genes found in zebrafish to be targets of Wnt signaling are cdx4 (23), MITF/nacre (27, 
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84, 107), and bozozok (83).  Based on analysis of these genes, mutation or knockdown 
of Wnt and members of the Wnt pathway has been shown to lead to phenotypes such as 
lack of somites and tailbud (Wnt-3A, mouse) (97) and mis-patterened mesoderm (Wnt-
8A, zebrafish) (51).  It is known that loss of bozozok (transcription factor that is 
regulated by β-catenin) and TCF3 (transcriptional repressor of Wnt target genes) leads to 
a variable loss of dorsal mesoderm and forebrain, and loss of forebrain and midbrain, 
respectively, in zebrafish (89).  Target genes of the Wnt pathway in other model 
organisms can be found at the web site www.stanford.edu/~rnusse/wntwindow.htm.   
 The FGF (fibroblast growth factor) pathway is a pathway important for limb 
development and lens induction (102).  The FGF ligand activates the FGF receptor 
(FGFR) which is a tyrosine kinase.  When the ligand binds, the receptor 
autophosphorylates the cytoplasmic domain of the receptor and the adaptor protein then 
serves as a bridge to link the phosphorylated receptor to the G protein Ras.  Once GAP 
(GTPase-activating protein) activates Ras, the Ras protein associates with Raf kinase.  
Raf kinase activates the MEK (Mitogen-Activated Protein Kinase Kinase) by 
phosphorylation, MEK then phosphorylates ERK (Extracellular Signal-Regulated 
Kinase), and then ERK enters the nucleus and phosphorylates a specific transcription 
factor (Figure 6). 
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Figure 6.  General FGF Pathway. (Modified from 33) 
 
 One example of a transcription factor that is activated by the FGF pathway is 
Mitf that binds to the p300/CBP histone acetyltransferase protein that enables it to 
activate the transcription of genes encoding tyrosinase and other proteins of the melanin-
formation pathway (71).  The FGFR1 gene contains an SPH element in the promoter of 
the human gene (60) and also has an SPH element in the zebrafish gene promoter as 
confirmed by visual inspection.  Therefore, there is also a chance that SBf/Staf may be 
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involved in the FGF signaling pathway.  Several zebrafish mutants have been generated 
by mutagenesis with ENU (ethylnitrosourea) for FGF genes.  Mutants in FGF8 lack a 
cerebellum and the midbrain-hindbrain boundary organizer (77).    Embryos mutant for 
FGF24 lack pectoral fin buds (30).  Mutation of the FGF10 gene leads to embryos that 
have no pectoral fin buds and a severely dysmorphic heatopancreatic ductal system (26, 
68).  Knockdown of FGF16, FGF19, and FGF21 by morpholino injection generated 
zebrafish embryos that lacked fin buds, impaired development of the forebrain, and 
haematopoiesis (58, 67, 106). 
 Members of the TGF-β (transforming growth factor-beta) super family signaling 
pathway dimerize in the C-terminal domain to make both homodimers and heterodimers 
with other TGF-β family members and then are secreted from the cell.  One member of 
the TGF-β super family is the BMP (bone morphogenetic proteins) family that induce 
bone formation, regulate cell division, apoptosis, cell migration, and differentiation. 
BMPs are thought to work through diffusion and the range of the diffusion is determined 
by the N-terminal amino acids (69).  Another member of the TGF-β super family is 
Nodal that signals through the activin receptor, and affects mesoderm and endoderm 
formation(90).  It is encoded by the cyclops and squint genes in zebrafish, and mutants 
display cyclopia or cyclopia and dorsal mesoderm defects respectively (89, 90).  TGF-β 
binds to a type II TGF-β receptor and then the type II receptor binds to a type I TGF-β 
receptor to phosphorylate either the serine or threonine on the type I TGF-β receptor.  
The type I receptor activates Smad 1 and 5 in the case of BMP, Smad 2 and 3 for Nodal.  
These phosphorylated Smads then bind to Smad 4 to form a transcription complex that 
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enters the nucleus (Figure 7).  Nodal also uses the FoxH1 co-activator in the 
transcription of Nodal controlled genes. Zebrafish that are mutant in the Smad 5, 
BMP2b, and BMP7 genes are severely dorsalized (89).   
 
Figure 7.  The Smad Pathway Activated by TGF-β Super Family Ligands. (modified from 33) 
 
A fourth developmental pathway is the Hedgehog pathway named after the hedgehog  
signaling protein in Drosophila.  Drosophila hedgehog works in concert with other 
molecules to lay down the basic framework of the embryo, determining anterior-
posterior relationships in developing structures(6).  There are three homologues of the 
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Drosophila Hedgehog found in vertebrates, sonic hedgehog (shh), desert hedgehog 
(dhh), and indian hedgehog (ihh).  Desert hedgehog is expressed in the testes, and mice 
mutant in dhh are defective in spermatogenesis (11).  Indian hedgehog is expressed in 
the gut and helps catalyze bone growth (12).  Sonic hedgehog has the greatest number of 
functions of the three hedgehog genes and is responsible for vertebrate limb formation 
and neural differentiation by directing motor neurons to only come from the ventral 
portion of the neural tube (56).  Hedgehog proteins bind the Patched receptor, and the 
signal is transduced by the interaction of Patched and Smoothened.   Patched is a 
negative regulator of Smoothened and in the absence of a Hedgehog ligand Smoothened 
is inactive and the Cubitus interuptus (Ci) protein tethered to the microtubules is 
cleaved.  When Ci is cleaved the free portion can enter the nucleus and act as a 
transcriptional repressor.  When a Hedgehog ligand binds to Patched it causes a 
conformational change in Patched that releases it from Smoothened.  Smoothened then 
releases Ci from the microtubules, and the intact Ci protein enters the nucleus and acts as 
a transcriptional activator (5, 54).  Loss of zebrafish Hedgehog signaling leads to ventral 
spinal cord defects, deficiencies in ventral forebrain specification, absence of an optic 
chiasm due to retinal axon guidance defects, absence of slow muscle fiber types, 
malformations of the dorsal aorta, ventral curvature of the body and defects in pectoral 
fin development (44). 
The Hedgehog signaling pathway controls the expression of the Wnt gene family, 
TGF-β/BMP family, and the Patched protein(6) (Figure 8). 
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Figure 8.  The Hedgehog Signal Transduction Pathway.  A).  In the absence of Hedgehog binding 
to Patched, the Ci protein is tethered to the microtubules by the Cos2 and Fused proteins.  This 
binding  allows for PKA and Slimb proteins to cleave Ci into a transcriptional repressor.  B).  When 
Hedgehog binds to Patched its conformation is changed and is released from the inhibition of 
Smoothened.  Smoothened then releases Ci from the microtubules and inactivates the cleavage protein 
PKA and Slimb.  The Ci protein enters the nucleus, binds a CBP protein and acts as a transcriptional 
activator. (Modified from 33) 
  
 
 In summary, two of the major developmental signaling pathways have 
components that contain SPH sites in the promoter.  In the case of the Wnt signaling 
pathway the transcription factors bozozok, cdx4, and MITF/nacre, whose expression is 
regulated by the Wnt pathway, lead to the loss of dorsal mesoderm and forebrain 
(bozozok), defects in haematopoiesis (cdx4), and loss of pigment cell differentiation 
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(MITF/nacre).  In the second signaling pathway, the FGF pathway, the FGF receptor 1 
(FGFR1) gene contains an SPH element in the promoter.  Loss of FGF signaling leads to 
a loss of dorsal ventral patterning.  The phenotypes described in Chapter III of 
morpholino injected zebrafish embryos such as a change in the cell fate of dorsal and 
ventral cells or circular system stress may be due to a loss in these developmental 
signaling pathways.  
 
GOAL 
 The research in this dissertation focuses on characterizing the role of SBF/Staf in 
both zebrafish development and transcriptional control.  The overall goal of this research 
is to provide insight into the role of SBF/Staf in general embryonic development as well 
as to determine the significance of the proximally-located SPH element for 
transcriptional control of the zebrafish U6 snRNA genes.  First I set out to determine the 
phenotype of a SBF/Staf morphant embryo and whether the phenotype could be rescued 
by in vitro transcribed mRNA.  In addition, I tested whether mutant SBF/Staf proteins, 
defective in either mRNA or snRNA activation domains, could rescue the phenotype.  
Furthermore, I investigated the enhancer function of the proximally-located SPH 
element in the zebrafish U6 snRNA genes. 
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CHAPTER II 
MATERIALS AND METHODS 
 
RAPID RNA ISOLATION FROM ZEBRAFISH EMBRYOS 
Embryos were collected at the indicated time-point and homogenized in GHCl 
buffer (7.5 M guanidinium hydrochloride, 0.025 M NaOAc pH 7.0, 5 mM DTT, 0.5% 
N-laurylsarcosinate, 0.5% DEPC) with a dounce homogenizer using 0.5 ml of GHCl 
buffer per 100 embryos.  The homogenate was then extracted once with an equal volume 
of acid phenol-CHCl3, and the upper phase was extracted with an equal volume of 
CHCl3.  The RNA was then ethanol precipitated by transferring the upper phase into a 
new tube with 50 µl of ethanol and 2 µl of 1M acetic acid for each 100 µl  of GHCl 
solution.  The sample was incubated at -20 ˚C overnight and the RNA was pelleted by 
centrifuging the sample at 14k RPM for 30 min at 4 ˚C.  The pellet was then 
resuspended in one half the starting volume of GHCl buffer.  The RNA was then 
reprecipitated and stated above, the pellet was washed in 100% ethanol, and dried briefly 
in a Speed Vac (Savant).  Once dried the RNA was resuspended in 20-30 µl of H2O-
DEPC and stored at -80 ˚C.  
 
PLASMID CONSTRUCTIONS 
Zebrafish small RNA genes 
Plasmid DNAs containing zebrafish U6 and U4 snRNA genes were constructed 
by G. Kunkel as described previously (22).  Briefly, zebrafish snRNA genes were 
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amplified by PCR from zebrafish genomic DNA (provided by A. Lekven), and DNA 
fragments were ligated into pGEM-T (Promega) according to the manufacturer’s 
protocol.  Primer sequences are given under “Oligos Used.”  To make the gene a 
“maxigene” a XhoI restriction site was inserted into the 3’ end of the zebrafish U6 
snRNA gene.  Maxigene versions of both zU6-1 and zU4-1 genes were constructed 
according to the QuickChange protocol (Stratagene) using primers 
ZU61MAXITOP/ZU61MAXIBOT and ZU4MAXITOP/ZU4MAXIBOT, respectively.  
Mutations within the SPH and TATA elements in the zebrafish U6-1 gene promoter 
were added using the QuickChange protocol with the primer sets, 
ZU61SPHMUTTOP/ZU61SPHMUTBOT and 
ZU61TATAMUTTOP/ZU61TATAMUTBOT, respectively.  All mutations, as well as 
the fidelity of the entire plasmid insert, were verified by sequencing of plasmid DNAs.  
Large-scale amounts of plasmid DNA were prepared using a Qiagen plasmid maxi kit. 
 
Zebrafish SBF/Staf plasmid DNAs used as templates for rescue mRNA synthesis 
Plasmid DNAs containing the zebrafish SBF/Staf ORF were constructed by G. 
Kunkel.  A cDNA containing the zebrafish SBF/Staf gene was obtained from Open 
Biosystems.  We named this plasmid pME18S-FL3/zZNF143. The ORF contained 
within this insert was lacking a full-length gene and contained a reading frame error in 
the coding region near the amino-terminus of the encoded protein.  Hence, in order to 
construct a full-length ORF ligated behind a T7 promoter, three DNA fragments were 
ligated as follows. The “correct” amino-terminal region fragment was prepared by RT-
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PCR using total RNA from zebrafish ZF4 cells and ligated into a pGEM-T vector 
(Promega).  This fragment was excised using KpnI and PvuII and purified by agarose gel 
electrophoresis.  The main body of the SBF/Staf ORF was excised from pME18S-
FL3/zZNF143 using PvuII and XhoI and purified by agarose gel electrophoresis.  The 
third DNA fragment was the pBlueScript SK (Stratagene) vector opened at KpnI and 
XhoI sites, and purified by chromatography on Sepharose CL-4B.  The three-fragment 
ligation reaction was used to transform E. coli XL1-Blue competent cells.  The insert of 
the subsequent plasmid, named pBS/FLZSBF, was sequenced entirely to verify its 
successful construction. A single myc tag was inserted at the amino-terminus of the 
encoded SBF/Staf protein using the QuickChange protocol and the primer set 
ZSBFMYCTOP/ZSBFMYCBOT.  All subsequent deletions within the zSBF/Staf ORF 
started with the parent plasmid pBS/mycZSBF and were constructed using the 
QuickChange protocol in which the oligonucleotides base-paired across the deletion 
endpoints and looped out the template DNA.  The DNA templates used in the in vitro 
transcription reaction were made using the QuickChange (Stratagene) protocol using 
oligos that looped out the DNA encoding for the amino acids to be deleted.  For each 
PCR-based reaction 5 µl of 10X Pfu Ultra HF Buffer, 1 µl 10 mM dNTPs mix, 50 ng 
plasmid template, 1.25 oligo mix (50 ng/µl each), 1 Pfu Ultra HF polymerase, and H2O 
up to 50 µl.  The PCR program used in the reaction was as follows:  95˚C for 3 min to 
denature the template; 95˚C for 30 sec, 50˚C for 1 min, 68˚C for 10 min, cycled 20 
times; then cooled to 4˚C. The reaction was then treated with DpnI for 2 hr at 37˚C.  Ten 
microliters of the reaction was used to transform chemically competent E. coli XL1-Blue 
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cells.  The plasmid DNA was isolated using the Qiagen mini-prep kit and inserts of all 
plasmids were sequenced completely to verify deletions and ensure that no other 
mutations were added to the SBF/Staf ORF.  Plasmid minipreps were prepared using a 
Qiagen miniprep kit, and such preparations were suitable for mRNA synthesis in vitro. 
 
TRANSFECTIONS 
Zebrafish ZF4 cells (ATCC #CRL-2058) were transfected in 6-well plates with 
500 ng of the appropriate U6 maxigene reporter plasmid plus 500ng of a U4 maxigene 
control plasmid for RNA recovery using 1:3 ratio (1µg DNA:3 µl Lipofectamine) of 
Lipofectamine 2000 (Invitrogen).  Total RNA was isolated 48 hr post-transfection and 
analyzed by RT-PCR.  For RT-PCR 105 ng of total RNA were treated with TURBO 
DNase (Ambion) per the manufacturer’s instructions.  The treated RNA was reversed 
transcribed using random hexamer primers (Roche) and Superscript III (Invitrogen) per 
the manufacturer’s instructions.  The resulting cDNA was then amplified by PCR using 
25 µl Go Green Master mix (Promega), 3 µl of 10mM forward primer, 3 µl of 10mM 
reverse primer, 2 µl (3.5ng) of cDNA, and H2O to a final volume of 50 µl.  Primer sets 
used were designed to amplify the expression of the U6 maxigene, U4 maxigene, and the 
5.8S rRNA (See Oligos Used). The PCR program used for amplification was 95˚C for 1 
min, 57˚C for 2 min, and 72˚C for 2 min. and was repeated 35 times.  The products were 
separated by electrophoresis on 18% polyacrylamide gels, stained with EtBr and the 
relative band intensities were quantitated using the Bio-Rad Gel Doc XR and Bio-Rad 
Quantity One software. 
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MICROINJECTION OF MORPHOLINOS INTO ZEBRAFISH EMBRYOS 
The wild-type fish used were the AB strain (Westerfield) and were maintained as 
described previously (104).  The morpholinos (MOs) used in the microinjections were 
designed to block the translation of SBF/Staf.  The sequence of the MOs and location of 
their target sequence is illustrated in Figure 9.   
 
 
Figure 9.  Morpholino Sequence and Location of Binding. A. Sequence of the two MOs used for 
embryo injections.  B.  Location on the SBF/Staf mRNA in which the MO will bind and block translation. 
 
The two translation blocking MOs (5 ng/nl each) were simultaneously injected and the 
phenotypes resulting from the injection were classified at 48 hpf.  To determine the 
specificity of the MO knockdown, a capped rescue wild-type SBF/Staf mRNA that 
contained a myc tag on the 5’ end and did not contain the binding sites for the MOs was 
transcribed in vitro using the mMESSAGE mMACHINE T7 Ultra kit (Ambion) per the 
manufacturer’s instructions.    Rescue mRNAs of SBF/Staf were prepared that either 
lacked the mRNA activation domain and snRNA activation domain simultaneously or 
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independently.  These rescue mRNAs were co-injected with both MOs and the 
phenotypes were classified at 48 hpf.   
 
REAL TIME PCR (qPCR) 
For each reaction the following was mixed: 1.5 µl of primer mix (30 pmol/µl of 
each), 10 µl 2X SYBR Green qPCR master mix (Applied Biosystems), cDNA sample, 
and H2O to 20 µl final volume.  The samples were cycled in an iCycler machine (Bio-
Rad) using the following program: 95˚C for 15 min; 95˚C for 30 sec, 58˚C for 30 sec, 
and 72˚C for 30 sec, cycled 40 times with data collected at this time; 95˚C for 1 min; 
55˚C for 1 min; and 55˚C for 10 sec, cycled 80 times with an increase in setpoint 
temperature by 0.5˚C which allowed for data for a melting curve to be collected and 
analyzed.  The iCycleriQ software (Bio-Rad) was used to analyze the qPCR data 
collected. 
 
OLIGOS USED 
PLASMID CONSTRUCTION 
 ZU61-305: 5’-AGG ACA CCTCAA CAA AAG CTC CTC-3’ 
CZU61+290: 5’-GCT CTA ATG CGC GGC TGG CAG TGC-3’ 
ZU41-300: 5’-GTG CGT TTG TAT GTT AGG AAA TAC G-3’ 
CZU4+132: 5’-GCC AGC AAC GCG GCT CGC CTT CAT C-3’ 
ZU61MAXITOP: 5’-ATG ACA CGC AAA TTC CCT CGA GGC GTG AAG CGT   
            TCC ATC-3’ 
ZU61MAXIBOT: 5’-GAT GGA ACG CTT CAC GCC TCG AGG GAA TTT GCG  
            TGT CAT-3’ 
ZU4MAXITOP: 5’-TTG AAA ACT TTA CCC GAC TCG AGG AAA TAC CCC  
         GCC GTG A-3’ 
ZU4MAXIBOT: 5’-TCA CGG CGG GGT ATT TCC TCG AGT CGG GTA AAG TTT  
         TCA A-3’ 
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ZU61SPHMUTTOP: 5’-CAC ATG AAA CAC ATA GTT CGA AGT CAC TGG TAT  
     A-3’ 
ZU61SPHMUTBOT: 5’-TAT ACC AGT GAC TTC GAA CTA TGT GTT TCA TGT  
     G-3’ 
ZU61TATAMUTTOP: 5’-CAG AAG TCA CTG GTA GCG CTA GCC GTC CTC  
         CAG A-3’ 
ZU61TATAMUTBOT: 5’-TCT GGA GGA CGG CTA GCG CTA CCA GTG ACT  
         TCT G-3’ 
ZSBFMYCTOP: 5’-GGG ATT GTA CCA TGG AGC AAA AAT TGA TTT CCG  
          AGG AGG ACT TGA TGC TGT TAG CCC AGG-3’ 
ZSBFMYCBOT: 5’-CCT GGG CTA ACA GCA TCA AGT CCT CCT CGG AAA  
           TCA ATT TTT GCT CCA TGG TAC AAT CCC-3’ 
F-KpnI zZNF143: 5’-AGC TTG GTA CCA TGC TGT TAG CCC AGG TGA ATC  
GG-3’ 
R-zZNF 143 279-300: 5’-ATC CAT CCT CCA GCT GAA TCA C-3’ 
RESCUE CONSTRUCTS 
MYCZSBFDEL2TO149TOP: 5’-TCC GAG GAG GAC TTG ATG CCT CAG TCC  
         AAC ACC ATC-3’ 
MYCZSBFDEL2TO149BOT: 5’-GAT GGT GTT GGA CTG AGG CAT CAA GTC  
         CTC CTC GGA-3’ 
MYCZSBFDEL151TO225TOP: 5’-GCA TAT ATT CAA CAT ATG CCT GGA GAA  
AAG GCC TTC CG-3’ 
MYCZSBFDEL151TO225BOT: 5’-CGG AAG GCC TTT TCT CCA GGC ATA TGT  
TGA ATA TAT GC-3’ 
MYCZSBFDEL2TO225TOP: 5’-TCC GAG GAG GAC TTG ATG GGA GAA AAG  
         GCC TTC CG-3’ 
MYCZSBFDEL2TO225BOT: 5’-CGG AAG GCC TTT TCT CCC ATC AAG TCC  
         TCC TCG GA-3’ 
 
RT-PCR  
 
F-zU61-17:  5’-GTG CTT GCT TCG GCA GC-3’ 
MAXI2U6: 5’-TTC ACG CCT CGA GGG AAT-3’ 
F-zU4 4-25: 5’-TTT GCG CAG TGG CAG TAT CGT-3’ 
R-zU4maxi: 5’-GGT ATT TCC TCG AGT CGG GTA AAG TTT TC-3’ 
F-5.8S2-25: 5’-AAC TCT TAG CGG TAC ACT CGG-3’ 
R-5.8S91-114:  5’-GCA AAG TGC GTT CGA AGT GTC GAT-3’ 
F-zU61
-
23: 5’-GCC GTC CTC CAG ACT CCC AGC TCG-3’ 
R-ZU61+193: 5’-CTG CGT ACT GAA CGC TTA AAC TCC-3’ 
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REAL-TIME PCR 
 
ZTFIIB510: 5’-TGC TAT TGC TTC AGC CTG CCT CTA-3’ 
CZTFIIB625: 5’-TGA AGC AGC GAC CAA TCT CCT TCT-3’ 
ZPLK1579:  5’-GTT GTG GGC TTT CAC GGG TTC TTT-3’ 
CZPLK1731” 5’-ACC CTG AAT AGT CTG GCG CAT GAA-3’ 
ZMDH1672: 5’-ATG CTG TGA ATG ACG AA GCT GGC-3’ 
CZMDH1791: 5’-AGA TGG CTT TGG CAG CAG ACA TTG-3’ 
ZSNAPC3555: 5’-TTT CAG ACT CTG CAT GTG TTG GGC-3’ 
CZSNAPC3671: 5’-TGG TAC CAT GTC TGG AGT GTT GCT-3’ 
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CHAPTER III 
 
THE BIOLOGICAL EFFECT OF SBF/STAF IN ZEBRAFISH DEVELOPMENT 
 
  
INTRODUCTION 
As stated in Chapter I, Myslinski, et. al. (2006) identified 1175 SBF/Staf binding 
sites (SPH elements) in 938 promoters of four different mammalian genomes.  The 
group also demonstrated that the presence of the SPH elements alone was sufficient to 
direct the expression of a luciferase reporter gene, suggesting that SBF/Staf can recruit 
the RNA pol II transcription machinery.  This raises the question of whether SBF/Staf is 
able to activate the expression of both mRNA and snRNA encoding genes. In order to 
further study the different roles of the two activation domains of SBF/Staf, the Kunkel 
lab attempted a knock-down of the SBF/Staf activity in cultured human cells using 
RNAi strategies. While the SBF/Staf RNA was successfully targeted with this approach, 
the endogenous protein levels could never be reduced by more than approximately 50%.  
Because this level of knockdown does not allow an accurate evaluation of SBF/Staf 
function, an alternate experimental system was required.  The zebrafish (Danio rerio) 
appeared to be a good model system to approach this question because of the following: 
SBF/Staf is conserved in vertebrates, but is absent in invertebrates (62); protocols are 
well established for the micro-injection of anti-sense morpholino oligos and synthetic 
mRNA to study gene knockdown, rescue, or gain of function phenotypes; zebrafish 
embryos develop rapidly outside the body of the mother; and embryos are optically clear 
allowing for the phenotypic outcome of the microinjection to be visualized easily.   Very 
little is known about the role of SBF/Staf in vivo.  According to an in situ hybridization 
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experiment submitted to the Zebrafish Information (ZFIN) website, SBF/Staf, referred to 
as znf143, does not show a specific localization (99).  This result is not surprising 
because the known role for SBF/Staf was in activation of the spliceosomal snRNA gene 
and a few encoding mRNAs and would be needed in all tissues.  However, we 
hypothesized that the downstream expression of other genes controlled by SBF/Staf may 
result in distinct phenotypes that may be uncovered by these experiments.  
 Expression of a specific protein can be suppressed throughout a developing 
embryo, producing a “knockdown” by the use of  morpholino (MO) antisense 
oligodeoxynucleotides (65).  Morpholinos are made up of a six member morpholine ring 
instead of the ribose ring and a nonionic phosphorodiamidate backbone in place of the 
anionic phosphodiester backbone.  It is these two features that keep the morpholino from 
being detected by the cell’s nucleases and being degraded.  The bases of a morpholino 
oligo are the same as for a DNA oligo.  Morpholinos can be designed to act on a 
particular mRNA and cause a “knockdown” by either blocking the ribosome from 
initiating translation or the mRNA splicing machinery from binding to the splice site.  
Using the MOs against SBF/Staf will allow for the characterization of the role of 
SBF/Staf in zebrafish embryonic development. 
  
RESULTS 
Morpholino injection into zebrafish embryos to knock down SBF/Staf protein levels 
 For the MO injection two MOs were synthesized, one complementary to the 
5’UTR of SBF/Staf mRNA (5’UTR MO) and another that is complementary to a region 
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including the 5’UTR and includes the SBF/Staf translation start site (1153 MO) (See 
Figure 9).  First I determined which MO would give the greatest proportion of embryos 
displaying a phenotype, and then I varied the concentration of each MO that was injected 
to determine whether the response was dose-dependent.  Different stock concentrations 
of each MO (1, 2, and 4 µg/µl) were injected into embryos resulting in an estimated final 
concentration in the embryo of 2.5, 5, and 10 µM respectively.  The MOs were injected 
as a 1:1 mixture with the stock final concentrations varying between 1, 2, and 4 µg/µl.   
When the 5’UTR and 1153 MOs were injected individually, the percentages of embryos 
that displayed a phenotype were as follows: for the 5’UTR at 48 hours post fertilization 
(hpf) 8, 5.5, and 11%; at 72 hrs 11, 8.5, and 11%; for the 1153 MO at 48 hpf 7.7, 16.7, 
and 17.7%; at 72 hpf 11.3, 24, and 31%.  When both MOs were injected together at 1, 2, 
or 4 µg/µl the percentages of embryos displaying a phenotype at 48 hpf were 3, 19, and 
95% and at 72 hpf the percentage of embryos were 6, 23, and 100% (See Figure 10).  All 
MO injections were repeated at least three times.  From these data it was determined that 
the most efficient knockdown was achieved with a combination of both MOs at a final 
concentration of 4 µg/µl.   
 
 
39 
 
 
Figure 10.  Morpholino Knockdown of SBF/Staf.  Embryos were injected with different amounts of two 
different morpholinos, either separately or together.  Embryos were scored at 48 and 72 hpf.  Data 
represent three independent injections.  The error bars show one standard deviation above and below the 
mean value. 
 
 When the combination of MOs was injected into the embryos, a varying degree 
of phenotypes was seen in the morphants (MO injected embryos).  Figure 11 illustrates 
the general classes of the morphant phenotypes seen 48 hours after injection.  The 
phenotypes range in severity of the morphant phenotypes is a usual result from MO 
injection.  Class 1 (kinked tail) and class 2 (curved body) morphants lack the ventral tail 
fin.  The kink in the tail (C1) and the general curved body (C2) maybe due to a change in 
the cell fates between the dorsal and ventral cells in the tail or a change in the growth 
rate of those cells (Figure 11B, C).  In the class 3 morphants, the somite chevron shape is 
absent.  There are opaque regions by the eye and the ear. This is indicative of cell death 
which can either be specific to a loss of the protein needed in the development of those 
structures or it may be a non-specific cell death caused by the MO injection triggering a 
p53 response.  There is not a yolk extension and there is edema around the heart with the 
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heart extended away from the body of the fish.  This heart phenotype may be due to 
stress on the circulatory system (Figure 11D).  In the phenotypes seen in the class 4 and 
class 5 morphants the shape of the somites and the yolk extension is lost as well as the 
tail bud length.  These morphants also have the extended heart and edema around the 
heart characteristic of circulatory system stress (Figure 11E, F).  In the class 6 morphant 
the phenotype is that the embryo has no eyes, ears, or cell differentiation except for the 
heart structures (Figure 11G).  The same range of phenotypes, in smaller proportions, 
was found when 5’UTR or 1153 MOs were injected individually. 
 
Figure 11. Phenotypes of Embryos Injected with MOs.  A:  Wild type 48 hpf embryo; B-G: Morphant 
phenotypic classes of 48 hpf embryos 
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Rescue of morphant phenotypes with different mRNA constructs of SBF/Staf 
 To confirm that the phenotypes seen in the injected embryos were due to the 
specific knock down of SBF/Staf and not a general toxic effect of the morpholino, a 
myc-tagged version of SBF/Staf was constructed so the protein expressed from the 
injected mRNA could be differentiated from the endogenous form.  Transcription of this 
gene by T7 RNA polymerase produced a mRNA that did not contain the complete 
binding sites for the MOs, and thus injection of this transcript is expected to rescue the 
mutants induced by MO addition.  First I determined the amount of mRNA to be 
injected that would not induce an overexpression phenotype.  Different amounts of the 
rescue SBF/Staf mRNA (0-300 ng/µl) were injected into wildtype embryos and then 
scored after 48 hrs for morphological abnormalities.  Figure 12A it is shows that 
between 15 and 30 ng/ul (0.48 nMFinal and 0.95 nMFinal in the embryo) of the rescue 
SBF/Staf mRNA alone does not induce an abnormal phenotype.  It should be noted that 
with the higher concentrations the SBF/Staf rescue mRNA does produce phenotypes 
similar to MOs knockdown.  This result was surprising but may be due to the fact that 
SBF/Staf has a global role in gene expression as seen in Carbon 2006 (60) and is further 
addressed in the Discussion section.  
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Figure 12. Gain of Function and Rescue of Phenotypes.  A:  Embryos were injected with increasing 
amounts of SBF/Staf mRNA and were scored at 48 and 72 hpf.  B:  Embryos were scored at 48 and 72 hpf 
after being injected with MOs and either 0,15, or 30 ng/μl rescue SBF/Staf mRNA.  In panel A, the error 
bars show one standard deviation above and below the mean value. 
 
The rescue SBF/Staf mRNA (30 ng/ul) was injected simultaneously with the MOs (4 
µg/µl) and the morphants were scored 48 and 72 hrs after the injection.  With the 
injection of the rescue SBF/Staf mRNA (30 ng/µl) and MOs the morphant phenotypes 
were reduced from 100% to only 33% of injected embryos illustrating that the 
knockdown by the MOs is specific for the knockdown of SBF/Staf (Figure 12B). 
 We next wanted to determine which of the two activation domains of SBF/Staf 
was responsible for the morphant phenotypes seen with the MO injection. We also 
wanted to determine if we could delineate the morphant phenotypes to those that were in 
response to losing the mRNA gene activation and those that could be due to a general 
loss in mRNA spicing (loss of the snRNA activation domain).  Three deletion mutants of 
SBF/Staf genes were constructed. Rescue mRNAs were synthesized that lacked the 
mRNA activation domain (∆2-149), the snRNA activation domain (∆151-225), or both 
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(∆2-225).  The ∆2-225 rescue mRNA was constructed to make sure that the phenotypes 
seen were not due to the simple loss of the DNA binding domain since this construct 
only contains the DNA binding domain and the C-terminal region of uncharacterized 
function.  Each of these rescue mRNAs were injected with the MOs and the phenotypes 
were scored 48 hrs after injection.   When the rescue ∆2-225 mRNA was injected it was 
unable to rescue the morphant phenotype, but both the ∆2-149 and ∆151-225 mRNAs 
were able to rescue approximately 50% of the embryos to a wildtype phenotype (Figure 
13).   These results indicate that both the mRNA and the snRNA activation domain are 
responsible for the morphant phenotypes seen in the injected embryos.  Luciferase 
transfection assays performed by Dr. Gary Kunkel demonstrated that when the deletion 
SBF/Staf mRNA constructs were expressed in ZF4 cells the ∆151-225 construct was 
able to activate the expression of the luciferase mRNA reporter gene, whereas the ∆2-
149 and ∆2-225 constructs were not (results not shown).  Therefore the deletion 
construct proteins function as expected in the zebrafish embryonic cell line. 
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Figure 13.  Rescue of Morphant Phenotypes with Different mRNA Constructs of SBF/Staf.  A:  
Diagrams of deletion rescue SBF/Staf mRNAs.  B:  Rescue data for injection of the different deletion 
rescue SBF/Staf mRNAs by morphant phenotypic class.  Each set of data represents the average of three 
independent injections. 
 
Injection of embryos with morpholinos affects expression of a U6 snRNA maxigene  
 
and various mRNA levels 
 
 Next we wanted to determine the effect of the knockdown of SBF/Staf on U6 
snRNA expression in the developing embryos.  U6 snRNA is expected to have a long 
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half-life, so I examined transient expression from an injected plasmid.  In order to 
differentiate from the endogenous U6 snRNA gene, embryos were injected with a U6 
maxigene construct (zU6Maxi) with and without MOs.  Total RNA was collected at the 
16 somite stage and processed for RT-PCR.  As a negative control, when embryos were 
injected with an unrelated MO that produces no phenotype the U6 maxi RNA level was 
unaffected (results not shown).  The expression of the U6 maxi snRNA gene was then 
quantified by densitometry of RT-PCR using oligos for the U6 maxi snRNA and 
normalized to 5.8S rRNA levels. When SBF/Staf expression is knocked down by the 
MOs the expression of the U6 snRNA maxigene was increased approximately ten-fold 
(Figure 14).    
 
Figure 14.  RT-PCR of Total RNA From Embryos Injected With MOs and a U6 Maxigene Promoter 
Construct.  (Top) Maxigene construct with arrows indicating the location of the primers used in PCR.  
(Bottom) PAGE gels of the RT-PCR reactions.   
 
This result was surprising because a simple expectation was that reduction of SBF/Staf, 
an activator for human U6 gene transcription, would result in decreased zebrafish U6 
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maxi expression.  Therefore, we investigated the effect of SBF/Staf knockdown on the 
expression of several mRNAs expressed during zebrafish development. 
 
qRT-PCR to determine the expression of different mRNAs in morpholino-injected  
 
embryos 
 
 We wanted to determine the effect of SBF/Staf knockdown on mRNA levels 
from genes that either contain an SPH-element in the promoter or that lack identifiable 
SPH sites.  Total RNA was collected from both uninjected and MOs-injected zebrafish 
embryos at the 16 somite stage, treated with DNase I, and processed to make cDNA.  
Oligos were used in qRT-PCR to detect the expression levels of 5.8S rRNA, TFIIB 
(Transcription Factor IIB), MDH (malate dehydrogenase), PLK (polo-like kinase), and 
SNAPc3 (a subunit of the small nuclear RNA activating complex).   5.8S rRNA levels 
were used as an RNA loading control in the qRT-PCR and TFIIB was used as a 
normalization control because its promoter does not contain an SPH-element.  MDH, 
PLK, and SNAPc3 genes all have SPH-elements in their promoters, and expression may 
be affected by the decrease in SBF/Staf protein with the injection of the MOs.  Similar to 
U6 maxi RNA levels, steady-state levels of these mRNAs were increased after injection 
of the MOs (Figure 15).  We do not understand the mechanism of this overall increase in 
both snRNA (U6) and mRNA levels upon MO-mediated knockdown of SBF/Staf, but 
we speculate about various possibilities in the discussion section.  Note that 5.8S rRNA 
levels are unaffected.    
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Figure 15. Quantitative RT-PCR of Total RNA from Embryos Injected with MOs Normalized to 
5.8S rRNA.  All data was normalized to 5.8S rRNA levels using the following equation: ΔCT,target = 
(CT,target – CT, 5.8S)MO - (CT,target – CT,5.8S)WT .  The error bars show one standard deviation above the mean 
value. 
 
A more careful analysis of the qRT-PCR data demonstrated a relatively modest decrease 
of mRNAs for genes containing SPH sites when compared to expression from the TFIIB 
gene which lacks an SPH site. To determine the expression levels of MDH, PLK, and 
SNAPc3 relative to TFIIB, the 2
-ΔΔCT
 method to compare the CT values was used as 
described in Livak and Schmittgen (53).  The expression levels of MDH, PLK, and 
SNAPc3 were decreased by approximately one-half after MO-injection, when compared 
to TFIIB (Figure 16). 
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Figure 16.  Quantitative RT-PCR of Total RNA from Embryos Injected with MOs.  All data was 
normalized to TFIIB using the following equation: ΔCT,target = (CT,target – CT, 5.8S)MO - (CT,target – CT,5.8S)WT;  
ΔΔCT,target  = (ΔCT,target – ΔCT,TFIIB).  Error bars show one standard deviation above the mean value. 
 
DISCUSSION 
From the MO injections we see that SBF/Staf has a global role in the 
development of zebrafish embryos.  This is supported by the general, overall phenotypes 
that were seen upon the injection of the MOs together and that the same morphant 
phenotypes were seen when the MOs were injected separately.   When MOs are co-
injected, there is a synergistic effect in the percentage of embryos that display a 
morphant phenotype.  The global role in development is also supported by a study by the 
Carbon lab which used a combined in silico and biochemical approach to identify 1175 
conserved SPH elements, the binding site for SBF/Staf, distributed in 938 mRNA gene 
promoters of four mammalian genomes (60). The SPH element shows a significant 
positional preference and occurs mostly within 200 bp upstream of the transcription start 
site. Chromatin immunoprecipitation assays with 295 of the promoters established that 
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90% contain bona fide SPH elements.  The co-injection of the rescue SBF/Staf mRNA 
with the MOs supports the conclusion that the morphant phenotypes result from a MO 
specific knockdown of the SBF/Staf protein because a majority of the morphant 
phenotypes are rescued.  The co-injection of SBF/Staf rescue mRNAs encoding 
deletions illustrated that both the mRNA activation domain and the snRNA activation 
domain are important to the zebrafish embryo development, because when each 
activation domain was deleted independently only half of the embryos were rescued.  It 
was only when both activation domains were deleted that the synthetic SBF/Staf mRNA 
could not rescue the morphant phenotype.  The data also shows that when the SBF/Staf 
rescue mRNA was injected at higher concentrations, the phenotypes seen in the 
morphants were the same as those seen with the knockdown of SBF/Staf.  Since 
SBF/Staf had been shown to have a role in the expression of many mRNAs by the 
Carbon lab (60) when SBF/Staf is overexpressed in the embryo there may also be an 
overexpression of many other mRNAs leading to a gain-of-function phenotype that is 
similar to the loss-of-function phenotype.  From the MO injections we also see an 
increase in the steady-state levels of mRNAs so the morphant phenotypes seen may be 
due to an increase of mRNA levels. 
 When the U6 maxigene plasmid was co-injected into embryos with the MOs, the 
expression level of the U6 maxigene was higher than when the U6 maxigene was 
injected alone (Figure 14).  This result was unexpected because SBF/Staf is known to be 
an activator of snRNA gene promoters (88).  However, this increase may be a general 
effect, because several mRNA levels were increased upon SBF/Staf MOs injection 
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(Figure 15).  The increase in the U6 maxigene plasmid expression may be due to the MO 
injection stabilizing the plasmid DNA but this is unlikely because there was also an 
increase seen in the endogenous mRNAs.  One scenario may explain the increase in 
RNA levels upon SBF/Staf knockdown.  Possibly, overall RNA stabilization is a result 
of decreased expression of a RNA turnover protein that has an SPH element in the 
promoter of its gene.  Therefore, there is a decrease in the expression of a gene encoding 
for a RNA destabilization protein due to the knockdown of SBF/Staf.   
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CHAPTER IV 
THE SIGNIFICANCE OF THE PROXIMALLY-LOCATED SPH ELEMENT 
FOR TRANSCRIPTION OF ZEBRAFISH U6 SNRNA GENES 
 
INTRODUCTION 
The snRNA SPH element was first recognized in chicken U1, U2, and U4 distal 
regions, but it is now clear that the SPH element is present in many vertebrate snRNA-
type promoters (55, 60, 78, 88, 109).  The SPH element was first discovered to be an 
enhancer of the chicken U1 snRNA expression by the Stumph lab and while there was a 
basal level of transcription without the SPH element, transcription was greatly enhanced 
by the presence of the SPH element (78).  The Kunkel lab determined that full activation 
of the human U6 promoter in vivo depends on there being both the Oct-1 and SPH 
element in the promoter and that the binding of SBF/Staf to the SPH element is 
dependent on Mg
+2
(22, 48).  Experiments using Sarkosyl to limit transcription to a 
single-round demonstrated that promoters containing either an Oct-1 or an SPH element 
support an increased number of pre-initiation complexes in vitro (49).  In humans it has 
been found that enhancers of snRNA genes and mRNA genes are not completely 
interchangeable, suggesting the mechanism of snRNA gene activation may be distinct 
(20).   
The zebrafish U6 snRNA gene promoters have an unusual organization in 
comparison to the human U6 snRNA promoter (Figure 17).  In the zebrafish U6 snRNA 
gene, the SPH element is located next to the TATA element in the proximal region of the 
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promoter.  Also, there is no distinguishable PSE (proximal sequence element) site and 
current studies in the Kunkel lab are being performed to determine if there is a bona-fide 
PSE site.  All other zebrafish snRNA genes have the standard promoter structure with an 
SPH element located ~230 bp upstream from the start of the snRNA gene.  With this 
location one could expect a different role for the SPH element and SBF/Staf in the 
expression of the zebrafish U6 snRNA gene.  Due to the unique location of the SPH 
element being next to the TATA element, there could be a potential protein-protein 
interaction between SBF/Staf and TBP (or another component of the RNA polymerase 
III transcription apparatus).  We set out to determine if this proximally located SPH 
element was a functional transcriptional element. 
 
Figure 17.  SPH Element Is Located in a Novel Position in Zebrafish U6 snRNA Promoters. 
 
RESULTS 
Proximally-located SPH element plays a functional role in U6 snRNA maxigene  
 
expression 
 
In the zebrafish U6 snRNA gene the SPH element is located in an unusual 
position (See Figure 17).  Previous work in the lab by G. Kunkel used DNase 1 
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footprinting with an end-labeled zebrafish U6 snRNA promoter and the DNA binding 
domain of SBF/Staf to determine that the SPH element is a binding site for SBF/Staf 
(Figure 18).  This binding was shown to be specific by using an electrophoretic mobility 
shift assay in which unlabeled SPH DNA sequence was able to compete with the binding 
of the SBF/Staf protein to labeled zebrafish U6 snRNA promoter sequence, and a non-
specific DNA sequence was not able to compete (Figure 18).  It should be noted that the 
human SBF/Staf was used in these experiments and that the human and zebrafish 
SBF/Staf proteins are 71% identical overall, about 50% identical in the snRNA 
activation domain, and almost 100% identical in the mRNA activation domain and DNA 
binding domain. 
 
 
Figure 18.  DNase I Footprint on zU6 Promoter and EMSA-Binding of hSBF/Staf to zU6 Gene.  (A) 
DNase I footprinting assay with increasing amounts of the DNA binding domain of hSBF/Staf against a 
end-labeled zU6 promoter. (B) EMSA-binding assay of hSBF-Staf to zU6 promoter DNA.  Increasing 
amounts of hSPH sequence was used to compete the interaction and hU6 Oct-1 DNA was used as a non-
specific competitor. 
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  Next, zebrafish U6 snRNA maxigene constructs were made in which an XhoI 
site was inserted in the 3’ end of the gene allowing for the distinction of the maxigene 
transcripts from the endogenous U6 snRNA.  The promoter that included 300 bp of 5’ 
flanking sequence including the SPH element and TATA box was cloned upstream of 
the U6 snRNA maxigene in the pGEM parental plasmid.  Plasmids were also 
constructed with the SPH and TATA box mutated independently by changing several bp 
within each element.  These plasmids were transiently transfected in the zebrafish ZF4 
cell line (ATCC #CRL-2058) using Lipofectamine 2000 (Invitrogen).  Total RNA was 
isolated from transfected cells, treated with DNase, and specific maxigene transcription 
was detected by RT-PCR analysis.  The expression of the U6 snRNA maxi gene was 
quantified from each of the different promoter constructs.  When the TATA-element was 
mutated the expression of the U6 snRNA maxigene was decreased to 22.7% of the 
expression from the wildtype promoter.  When the SPH element was mutated, 
expression was decreased to 20.6% of wildtype (average of three independent 
transfection experiments).  From the data in Figure 19 it can be determined that the 
proximally-located SPH element is important for the transcription of the zebrafish U6 
snRNA gene despite its unusual location.  
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Figure 19.  RT-PCR of Total RNA Recovered from Transiently Transfected ZF4 Cells. (Top) 
Maxigene construct with arrows indicating the location of the primers used in PCR.  (Bottom) PAGE gels 
of the RT-PCR reactions.  Diagram above each set of lanes indicates the location of the promoter mutation 
with a red X. 
 
Injection of embryos with morpholinos affects expression of a U6 snRNA maxigene  
 
and U6 snRNA maxigene mutants 
 
 Since in previous experiments the injection of MOs into embryos increased the 
steady-state levels of U6 maxigene transcript, I decided to inject embryos with the 
different SPH and TATA mutant plasmids under these conditions.  RNA was collected 
at the 16 somite stage and processed for RT-PCR.  The expression of the U6 maxi 
snRNA gene was then quantified using oligos for the U6 maxi snRNA and normalized to 
5.8S rRNA levels. 
When the TATAMUT construct was injected with MOs the expression of the U6 
maxigene was decreased to 1.6% of the expression of the U6 maxigene construct with 
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the wildtype promoter.  These data support previous studies that both the TATA element 
and SBF/Staf are needed to obtain the highest levels of human U6 snRNA gene 
transcription.  These data where further supported with the SPHMUT construct being 
injected with MOs and the expression of the U6 maxigene decreasing only to 26.8% of 
the expression of the U6 maxigene with a wildtype promoter (Figure 20).   
 
 
Figure 20. RT-PCR of Total RNA from Embryos Injected With MOs and a U6 Maxigene Mutant 
Promoter Constructs.  (Top) Maxigene construct with arrows indicating the location of the primers used 
in PCR.  (Bottom) PAGE gels of the RT-PCR reactions.  Note that the first six lanes are that same as in 
Figure 13. 
 
DISCUSSION 
 For human RNA polymerase III snRNA gene promoters, such as U6 snRNA, the 
SPH-element is located approximately 230 bp upstream from the transcription start site.  
In the case of the zebrafish U6 snRNA gene the SPH-element is located in the proximal 
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region of the promoter, next to the TATA box.  We set out to determine if this SPH-
element played a role in the expression of the zebrafish U6 snRNA gene.  First we 
confirmed that SBF/Staf could bind at the SPH-element using DNase I footprinting and 
EMSA.  When the U6 snRNA maxigene expression in transfected ZF4 cells was 
quantified using RT-PCR it was shown that the proximally-located SPH-element is not 
only bound by SBF/Staf, but also SBF/Staf has a role in the expression of the U6 snRNA 
gene.  Unlike mammalian U6 snRNA promoters the expression of the U6 maxigene is 
not completely abolished with the loss of the TATA element.   Possibly the SPH-element 
alone can function as a basal promoter.  Alternatively, other unidentified proximal 
elements may play a role(s).  For example the zU6 snRNA promoter may contain a PSE, 
typically found in snRNA genes.  It is to the advantage of the organism to have multiple 
basal promoter elements for an essential gene in mRNA maturation, because without the 
splicing machinery no functional proteins could be produced by the cell.  This unusual 
location of the SPH element is also seen in mRNA gene promoters, where it is 
sometimes present at the approximately -30 position in place of the TATA-element (60).  
It should be noted that for other zebrafish snRNA promoters the SPH element is located 
in the normal location; only the U6 snRNA gene is different.  In the zebrafish embryo 
the TATAMUT and SPHMUT plasmid constructs illustrated that the proximally-located 
SPH element does have a role in the transcription of the U6 maxigene by the decrease in 
the level of expression of the U6 maxigene when both SBF/Staf is knocked down and 
the SPH-element is mutated.   
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There are a couple possibilities for why the decrease of the expression of the U6 
maxigene seen with the TATAMUT and SPHMUT constructs was different in the 
transfected ZF4 embryonic cell line versus the whole embryo.  There could be a different 
chromatin structure of the plasmids in the ZF4 cells versus the embryo. Alternatively, 
the higher level of expression seen in the ZF4 cells transfected with the TATAMUT 
versus the embryo injected with the TATAMUT could be due to non-specific 
transcription in the ZF4 cells. 
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CHAPTER V 
SUMMARY 
The level of eukaryotic gene expression is in most cases controlled by the gene’s 
basal promoter as well as enhancer elements that direct binding of activator proteins.  
The U6 snRNA promoter provides a simple model system to study the mechanism of 
eukaryotic transcription.  SBF/Staf is one important activator protein that binds the SPH 
element in U6 snRNA enhancers.  However, this protein has the ability to stimulate 
transcription of both snRNA and protein-coding genes through distinct activation 
domains.  Using zebrafish as a model I first looked at the role that the two activation 
domains of SBF/Staf play in zebrafish development.  I also investigated the role of the 
unusual proximal location of the SPH element in the transcription of zebrafish U6 
snRNA genes. 
Work described in Chapter III illustrates the phenotypic effects of a knockdown 
of the SBF/Staf protein on a developing zebrafish embryo.  Two translation blocking 
MOs that were designed against SBF/Staf were injected either independently or together 
into zebrafish embryos.  When the morphant phenotypes were scored, the phenotypes 
seen varied from a simple tail tip malformation to an almost complete loss of cell 
differentiation.  To confirm that the morphant phenotypes were the result of the MO 
knockdown of SBF/Staf, a capped rescue mRNA that did not contain the binding sites 
for the MOs was synthesized.  When the rescue mRNA was injected with the MOs into 
the zebrafish embryos most of the embryos displayed a wildtype phenotype.  Using this 
rescue strategy I then attempted to delineate the morphant phenotypes that were due to a 
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lack of the SBF/Staf mRNA activation domain and those due to a lack of the snRNA 
activation domain.  Rescue mRNAs were synthesized lacking either or both the 
activation domains and were co-injected with the MOs.  The rescue mRNAs that had 
either the mRNA activation domain only (Δ2-149) or the snRNA activation domain only 
(Δ151-225) were both able to rescue the morphant phenotype to a wildtype phenotype in 
about 50% of the embryos.  Remaining mutant embryos were not distinguishable 
between the two different rescue mutants.  The rescue mRNA that lacked both activation 
domains (Δ2-225) was not able to rescue the morphant phenotypes. There appeared to be 
an increase in the severity of the phenotypes that remained after the injection of this 
mRNA and the MOs.  The phenotypes described in Chapter III of morpholino injected 
zebrafish embryos, such as a change in the cell fate of dorsal and ventral cells or circular 
system stress, may be due to a loss in the Wnt and FGF developmental signaling 
pathways. 
Next I wanted to study the effect on U6 snRNA transcription and several mRNA 
gene targets by the loss of the SBF/Staf protein.  Using the U6 maxigene constructs to 
inject with the MOs, an increase in the steady-state levels of the U6 snRNA maxigene 
expression was found.  This increase was also seen when I looked at the mRNA levels 
for several genes. Upon a more careful analysis, I found that the increased levels of 
expression of  mRNAs for genes containing SPH sites were less than for a control gene 
lacking an SPH site in its promoter.  A possible reason for the apparent global increase 
in the steady-state levels of both the snRNA and the mRNAs could be due to the loss of 
a RNA destabilization or nuclease protein that is responsible for RNA turnover and has 
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an SPH element in its promoter.  Further studies could use a MO designed to knock 
down a protein with these functions.  One could determine whether U6 snRNA 
maxigene and mRNA expression is affected.  In addition, injection of a synthetic mRNA 
encoding the putative RNA destabilization protein would be predicted to rescue the 
elevated RNA levels caused by SBF/Staf MOs.  Myslinski et. al. detected a number of 
mammalian SBF/Staf target gene promoters that direct transcription of genes important 
in RNA metabolism(60). 
In Chapter IV I chose to investigate the role of the proximally-located SPH 
element in the zebrafish U6 snRNA gene.  When we first decided to use the zebrafish 
model system it was discovered that while all the rest of the snRNA gene promoters 
have architectures similar to the human snRNA promoters, the zebrafish U6 snRNA 
genes did not.  The SPH element is located next to the TATA element and this raised the 
question of whether or not this element was functional.  Previous DNase I footprinting 
and EMSA binding assays using the zebrafish U6 snRNA promoter DNA sequence 
showed that SBF/Staf binds to this proximally-located SPH element in a specific 
manner.  To study whether the proximally-located SPH element was functional, U6 
maxigene constructs were made with a mutant SPH element (SPHMUT) or a TATA 
element (TATAMUT).  Using transfected zebrafish embryonic cells I found that the 
SPH element was functional because there was a decrease in the expression of the U6 
maxigene when the SPH element was mutated.  The TATAMUT and SPHMUT 
constructs were also injected into zebrafish embryos with the MOs to investigate the 
functionality of the proximally-located SPH element in vivo.  As expected, when the 
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TATA element was mutated the expression of the U6 maxigene dropped dramatically. 
When the SPH element was mutated the decrease in the expression of the U6 maxigene 
was similar to that seen in the transfected cells.  These experiments illustrated that the 
SPH element plays an important role at its proximal location.  Further studies need to be 
done to determine if this unusual location next to the TATA element facilitates protein-
protein interaction between SBF/Staf and components of the transcription machinery, for 
example, TATA-binding protein (TBP) or TBP-associated proteins.  
The results presented in this dissertation have increased the knowledge of an 
enhancer element and activator protein that has recently been shown to have a more 
global role in gene transcription than previously thought.  Both activation domains of 
SBF/Staf have been shown to be important in zebrafish development, and the 
proximally-located SPH element has been shown to be functional regardless of its 
unusual location for a snRNA gene.  Future studies will illuminate specific 
developmental targets of SBF/Staf activation, as well as biochemical mechanisms by 
which the protein works at snRNA and mRNA gene promoters. 
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APPENDIX 
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mRNA BINDING PROTEINS FROM Trypanosoma brucei 
 
 
The following is a list of papers published, as well as my contribution to those papers, 
from the Cruz-Reyes lab: 
 
Halbig, K., Sacharidou, A., Cifuentes-Rojas, C., De Nova-Ocampo, M., Cruz-Reyes, J. 
2006.  Preferential interaction of a 25 kDa protein with an A6 pre-mRNA substrate for 
RNA editing in Trypanosoma brucei. International Journal of Parasitology. 2006 
Oct;36(12):1295-304. 
 
The purpose of this study was to search for protein interactions with a functional 
editing substrate by using a site-specific radiolabeled RNA single-site labeled mRNA 
and “zero-distance” photocrosslinking with mitochondrial lysate fractions that were 
partially purified by ion-exchange chromatography.  A 25 kDa crosslink was observed 
that was protein-dependent and was shown to be specific through competition 
experiments with both homologous and heterologous RNA competitors.  Mapping and 
substrate truncation analyses suggest that the crosslinking activity primarily targeted a 
predicted stem-loop region containing the first editing sites.  Pre-annealing with guide 
RNA abolished crosslinking suggesting that pre-mRNA structure may be required. 
Interestingly, this preferential protein interaction with the A6 substrate seemed to require 
ATP, but not hydrolysis. As in other biological systems, fine regulation in vivo may be 
brought about by transient networks of relatively low-specificity interactions in which 
additional factors bind to mRNAs and/or editing complexes in unique higher-order 
assemblies.   
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For this study I was responsible for the production of all RNA substrates, growth 
of the PF trypanosomes, the preparation of the mitochondrial extracts, and the 
enrichment of the editing complex by the use of chromatography.  I also performed the 
crosslinking assays including all competition assays, the adenylation assays, the 
nucleotide requirement assays, and the mRNA structural requirement assays.  Finally I 
also performed the isopycnic sedimentation assay of the 25 kDa crosslink in both BF and 
PF extracts.  I presented this work at the 2005 Gordon Research Conference in RNA 
Editing in Ventura, CA.  
 
Miller, MM., Halbig, K., Cruz-Reyes, J., Read, LK. (2006).  RBP16 stimulates 
trypanosome RNA editing in vitro at an early step in the editing reaction. RNA. 2006 
Jul;12(7):1292-303 
 
This work was done in collaboration with Dr. Laurie Read’s laboratory and all 
the experiments were done by Melissa Miller.  I contributed the purified editing complex 
used in the work.   
Sacharidou, A., Halbig, K., Cifuentes-Rojas, C., Hernandez, A., Dangott, L., De Nova-
Ocampo, M.,Cruz-Reyes, J. (2006).  RNA editing complex interactions with a site for 
full-round U deletion in Trypanosoma brucei. RNA. 2006 Jul;12(7):1219-28 
The basic enzymatic activities and protein composition of these RNA editing 
complexes had been under intense study by several labs, but the specific protein 
interactions with functional pre-mRNA/gRNA substrates had not been studied.  Editing 
complexes purified through extensive ion-exchange chromatography and 
immunoprecipitation make specific cross-linking interactions with A6 pre-mRNA 
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containing a single 32P and photoreactive 4-thioU at the scissile bond of a functional 
site.  For full-round U deletion at least four direct protein-RNA contacts are detected at 
this site by cross-linking. All four interactions (p40, p50, p60, and p100) are stimulated 
by unpaired residues just 5' of the pre-mRNA/gRNA anchor duplex, but strongly 
inhibited by pairing of the editing site region. All four of the interactions also co-purified 
with known members of the editing complex.  Furthermore, competition analysis with 
homologous and heterologous transcripts suggests preferential contacts of the editing 
complex with the mRNA/gRNA duplex substrate. This apparent structural selectivity 
suggests that the RNA-protein interactions observed may be involved in recognition of 
editing sites and/or catalysis in assembled complexes. 
For this study I was responsible for the preparation of the mitochondrial extracts and 
the enrichment of the editing complex via chromatography.  I also performed the 
crosslinking assays of the A6 mRNA and gRNA with the editing complexes with 
different levels of purified editing complex as well as the culturing of the PF 
trypanosomes. 
 
 
 
Cifuentes-Rojas, C., Halbig, K., Sacharidou, A., De Nova-Ocampo, M.,Cruz-Reyes, J. 
(2005).  Minimal pre-mRNA substrates with natural and converted sites for full-round U 
insertion and U deletion RNA editing in trypanosomes.  Nucleic Acids Res. Nov 
23;33(20):6610-20. 
 
 The structural and functional composition of editing complexes is intensively 
studied, but the molecular interactions in and around editing sites was not completely 
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understood, which was the focus of this study. In this study, a systematic analysis of 
distal RNA requirements for full-round insertion and deletion by purified editing 
complex was performed. Minimal substrates were defined for efficient editing of A6 and 
CYb model transcripts, and established a new substrate, RPS12. Important differences 
were observed in the composition of substrates for insertion and deletion. It was also 
shown for the first time that natural sites can be artificially converted in both directions: 
from deletion to insertion or from insertion to deletion. The site conversions enabled a 
direct comparison of the two editing modes at common sites during substrate 
minimization and demonstrate that all basic determinants directing the editosome to 
carry out full-round insertion or deletion reside within each editing site. Surprisingly, I 
was able to engineer a deletion site into CYb, which exclusively undergoes insertion in 
nature. 
For this study I was responsible for the preparation of the CYb mRNA and gRNA 
constructs for both insertion and deletion editing as well as the preparation of the 
mitochondrial extracts and the enrichment of the editing complex.  I also performed the 
editing assays for both CYb deletion and insertion. 
Halbig, K., De Nova-Ocampo, M., Cruz-Reyes, J. (2004) Complete cycles of 
bloodstream trypanosome RNA editing in vitro. 
RNA. Jun;10(6):914-20.  
Previous work on the requirements for RNA editing in trypanosomes had only been 
studied in the procyclic or insect form of the parasite because it was the only form in 
which an in vitro assay had been established.  During the life cycle of Trypanosome 
77 
 
brucei it also is found in the bloodstream form when it has infected a mammal host.  The 
establishment of an in vitro assay that recreates efficient RNA editing in bloodstream T. 
brucei would be a valuable tool for mechanistic studies of regulation. In this work Dr. 
Monico De Nova-Ocampo and I were able to establish a robust in vitro system that 
reconstitutes full cycles of both U insertion and U deletion in bloodstream trypanosomes, 
and allowed for the first direct comparisons of the in vitro systems for strains of 
mammalian and insect stages.   
For this study I infected the rats with the BF trypanosomes, prepared the 
mitochondrial extracts and the enrichment of the BF editing complex via 
chromatography.  I also ran isopycnic sedimentation on both PF and BF mitochondrial 
extracts as well as assayed for the location of the editing complex by adenylation.  
Finally I developed all the figures for the paper as well as performed the quantitation of 
the editing assays.  I presented this work at the Molecular Parasitology Meeting XIV at 
Marine Biological Laboratory in Woods Hole, MA in 2003. 
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